Leadership
Vincent Simmon, PhD
Chief Regulatory Officer

Vincent Simmon has over 30 years of experience growing biotechnology companies and developing products in the biotechnology industry. He served as a Governor of the Emerging Companies Section of BIO (Biotechnology Industrial Organization) and as a director of the Chemical Industries Institute for Toxicology (Research Triangle Park). He has been CEO, COO, and a director of public and private biotechnology companies since 1990, including Alpha 1 Biomedicals, Cortex Pharmaceuticals, Merrimack Pharmaceuticals, and Xytis, Inc.
At Merrimack Pharmaceuticals, Vincent as COO was responsible for progressing its lead compound into Phase II clinical studies, and participated in raising more than $95 million in private financing.
Currently he is a member of the board of directors of Innovative NeuroTechnologies, Personalized Pharmaceuticals Systems, and Thuris Corporation. Vincent has personally supervised the submission and acceptance of more than ten INDs.
Vincent received his B.A. in Biology and Chemistry from Amherst College in Massachusetts, his M.S. in Plant Physiology from the University of Toledo in Ohio, and earned his Ph.D. in Molecular and Microbiology from Brown University in Rhode Island.